RNS Number:1777K
Tepnel Life Sciences PLC
17 April 2003



FOR IMMEDIATE RELEASE



                                                                   17 April 2003

 Tepnel Life Sciences PLC ('Tepnel' or 'the Company') Announces Resignation of
                               Technical Director





Manchester, UK. 17 April 2003...Tepnel Life Sciences PLC (AIM: TED), the
UK-based international life sciences instrumentation and services company,
announces that Peter Highfield, the Company's Technical Director, has resigned
today in order to pursue other business interests. Following Dr Highfield's
resignation, Tepnel has decided not to appoint a direct replacement, but instead
to absorb Dr Highfield's duties and responsibilities into the excellent and
highly capable technical team within the Company.



Ben Matzilevich, CEO, said "I would like to thank Peter for his assistance in
the development of Tepnel's technology over the past five years, and wish him
well with his future endeavours."



                                     -ends-



For Further Information



Tepnel Life Sciences
Ben Matzilevich, CEO

Gron Ffoulkes-Davies, Finance Director

0161 946 2200



HCC De Facto Group

David Dible / Mark Swallow

020 7496 3300





Notes to Editors



Tepnel Life Sciences is a UK-based international life sciences instrumentation
and services company with a 'tri-polar' strategy focused on providing the
biomedical industry with high-throughput automated DNA purification systems,
manual DNA purification kits and reagents, as well as scientific services for
nucleic acid purification, drug analysis, genotyping and genetically modified
foods.



The Company was founded in 1992 to exploit DNA technology generated at UMIST
(University of Manchester Institute of Science and Technology) and is quoted on
the AIM segment of the London Stock Exchange (AIM: TED).



www.tepnel.com






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOAGUUCPCUPWGCM